| Company Name: |
Quality Control Solutions Ltd.
|
| Tel: |
0755-66853366 13670046396 |
| Email: |
orders@qcsrm.com |
| Products Intro: |
Product Name:Vinpocetine Impurity 2 (Oxime) CAS:102341-40-2 Purity:95% HPLC Package:10mg;25mg;50mg;100mg
|
| Company Name: |
Shenzhen SUNGENING Bio-Medical Co., Ltd.
|
| Tel: |
0755-28967200 13631290199 |
| Email: |
wxf@sungening.com |
| Products Intro: |
Product Name:Vinpocetine Impurity 11 CAS:102341-40-2 Purity:99% HPLC or More Package:10MG;25MG;50MG;100MG
|
|
| | Vinpocetine Impurity Basic information |
| Product Name: | Vinpocetine Impurity | | Synonyms: | (41S,13aS)-13a-ethyl-2,3,5,6,13,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridin-12(41H)-one oxime;Vinpocetine Impurity 2 (Oxime);Eburnamenin-14(15H)-one, oxime, (3α,16α)- (9CI);Vinpocetine Impurity 2 (Vinpocetine Oxime);Vinpocetine Impurity | | CAS: | 102341-40-2 | | MF: | C19H23N3O | | MW: | 309.41 | | EINECS: | | | Product Categories: | | | Mol File: | 102341-40-2.mol |  |
| | Vinpocetine Impurity Chemical Properties |
| Boiling point | 507.5±52.0 °C(Predicted) | | density | 1.38±0.1 g/cm3(Predicted) | | pka | 11.49±0.40(Predicted) |
| | Vinpocetine Impurity Usage And Synthesis |
| | Vinpocetine Impurity Preparation Products And Raw materials |
|
|
Tag:Vinpocetine Impurity(102341-40-2)
Related Product Information
|
|
sodium (41S,12R,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12, 13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5] naphthyridine-12-carboxylate
methyl (41R,12S,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
ethyl apovincaminate
(3alpha,16alpha)-eburnamenine-14-carboxylic acid
16,17-Dihydroapovincamine
methyl (41R,12R,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
ethyl (41S,13aR)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
ApovincaMinic Acid Ethyl Ester N-Oxide
(41S,12S,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylic acid
methyl (41S,12S,13aS)-13a-ethyl-12-hydroxy-8-methoxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
ethyl (41R,13aS)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
(+)-(14β)-Dihydrovinpocetine
(-)-DihydroapovincaMinic Acid Ethyl Ester
(41S,12S,13aS)-12-(ethoxycarbonyl)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydroindolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine 4(1H)-oxide
ethyl (41S,12R,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
Vinpocetine
(3alpha,14beta,16alpha)-14,15-dihydro-14-hydroxyeburnamenine-14-carboxylic acid
Morpholine, 2-[(2-ethoxyphenoxy)methyl]-4-(phenylmethyl)-
|